Transforming the Treatment of NSCLC Options
A Case-Based Program: Transforming the Treatment of NSCLC Options for First-Line Treatment of Metastatic EGFR Mutation-Positive Disease and Immunotherapy for Unresectable Stage III Disease SPEAKER |
|
A Case-Based Program: Transforming the Treatment of NSCLC Options for First-Line Treatment of Metastatic EGFR Mutation-Positive Disease and Immunotherapy for Unresectable Stage III Disease SPEAKER |
|